SCGC-Backed Innovative Antibody Drug Firm Gets $150M Funding From Sino Biopharm

This Data Is Locked!

This area is available only to Subscribers.

Akeso Biopharma, an innovative biotechnology company, announced that it has raised nearly US$150 million in a series D funding round led by private equity firm... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?